Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits. The post MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs appeared first on MedCity News.
A webinar on Thursday, December 12 from Noon to 1 pm ET will focus on how companies are meeting these challenges. The post How Can Employers Give Staff the Best Care Amidst Rising Healthcare Costs? appeared first on MedCity News.
By aligning innovative scientific insights with strategic commercial pathways, the industry has the potential to fulfill its early promise – delivering safe, effective therapies that improve patient outcomes and create new opportunities for growth in the biopharmaceutical sector. The post Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine appeared first on MedCity…
The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn’s disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The post Teva and Sanofi Mid-Stage Data Reveal Shows…
En el Valle de San Luis, al sur de Colorado, las nubes se elevan sobre las imponentes montañas de la cordillera Sangre de Cristo. Un coro de mirlos gorjea mientras revolotea entre los juncos de un refugio de vida silvestre. Grandes campos cultivados en forma de círculo, intercalados con arbustos autóctonos, dan una sensación de…
By shifting the focus for consumers earlier in the care continuum, AI has the potential to play a transformative role in prevention and personalized health solutions-particularly for health conditions that impact hundreds of millions of people worldwide. The post The Biggest Opportunity for AI in Healthcare Isn’t Disease, It’s Wellness appeared first on MedCity News.
The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare telehealth access and programs like SNAP. The post How Healthcare Leaders Are Reacting to the Government Shutdown appeared first on MedCity News.
The Social Security Administration is backing off a plan it announced in March to withhold 100% of many beneficiaries’ monthly payments to claw back money the government had allegedly overpaid them. Instead, the agency will default to withholding 50% of old-age, survivors, and disability insurance benefits, the agency said in an “emergency message” to staff…
The FDA asked Cytokinetics for the Risk Evaluation and Mitigation Strategy after it had already accepted the application for aficamten, a potential competitor to Bristol Myers Squibbs heart drug Camzyos. Analysts say this development could signal a change in FDA thinking about risk management for the broader drug class. The post FDA Pushes Out Decision…
Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…